900 related articles for article (PubMed ID: 9462625)
1. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
Bergquist A; Glaumann H; Persson B; Broomé U
Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
3. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
4. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H
Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
[TBL] [Abstract][Full Text] [Related]
5. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis.
Tischendorf JJ; Meier PN; Strassburg CP; Klempnauer J; Hecker H; Manns MP; Krüger M
Scand J Gastroenterol; 2006 Oct; 41(10):1227-34. PubMed ID: 16990210
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy.
Brandsaeter B; Isoniemi H; Broomé U; Olausson M; Bäckman L; Hansen B; Schrumpf E; Oksanen A; Ericzon BG; Höckerstedt K; Mäkisalo H; Kirkegaard P; Friman S; Bjøro K
J Hepatol; 2004 May; 40(5):815-22. PubMed ID: 15094230
[TBL] [Abstract][Full Text] [Related]
7. Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis.
Björnsson E; Angulo P
Am J Gastroenterol; 2007 Aug; 102(8):1677-82. PubMed ID: 17433022
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
Garioud A; Seksik P; Chrétien Y; Corphechot C; Poupon R; Poupon RE; Chazouillères O
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305
[TBL] [Abstract][Full Text] [Related]
9. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
Gorgun E; Remzi FH; Manilich E; Preen M; Shen B; Fazio VW
Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
[TBL] [Abstract][Full Text] [Related]
10. Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden.
Bergquist A; Said K; Broomé U
Scand J Gastroenterol; 2007 Jan; 42(1):88-93. PubMed ID: 17190768
[TBL] [Abstract][Full Text] [Related]
11. Primary sclerosing cholangitis and malignancy.
Boberg KM; Lind GE
Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):753-64. PubMed ID: 22117640
[TBL] [Abstract][Full Text] [Related]
12. High lifetime risk of cancer in primary sclerosing cholangitis.
Claessen MM; Vleggaar FP; Tytgat KM; Siersema PD; van Buuren HR
J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
14. Primary sclerosing cholangitis and cholangiocarcinoma.
Lazaridis KN; Gores GJ
Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
[TBL] [Abstract][Full Text] [Related]
15. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
Bergquist A; Broomé U
Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
[TBL] [Abstract][Full Text] [Related]
19. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
Zen Y; Quaglia A; Heaton N; Rela M; Portmann B
Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890
[TBL] [Abstract][Full Text] [Related]
20. Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis.
Tanaka A; Takamori Y; Toda G; Ohnishi S; Takikawa H
Liver Int; 2008 Aug; 28(7):983-9. PubMed ID: 18397233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
